1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SEC63 CTRPv2 pan-cancer AAC 0.081 0.01
mRNA FBXO46 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA GGT7 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA RHBDD2 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA OAZ1 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA CTD-2349B8.1 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA PPIH CTRPv2 pan-cancer AAC 0.085 0.01
mRNA LMAN2 CTRPv2 pan-cancer AAC -0.083 0.01
mRNA TMX1 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA NPAS2 CTRPv2 pan-cancer AAC -0.084 0.01
Download CSV